Short Interest in Pharma Mar, S.A. (OTCMKTS:PHMMF) Grows By 43.4%

Pharma Mar, S.A. (OTCMKTS:PHMMF - Get Free Report) was the target of a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 32,700 shares, an increase of 43.4% from the February 13th total of 22,800 shares. Approximately 0.2% of the company's stock are sold short. Based on an average trading volume of 100 shares, the short-interest ratio is currently 327.0 days.

Pharma Mar Price Performance

Shares of PHMMF stock remained flat at $102.08 on Wednesday. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.55 and a quick ratio of 2.01. Pharma Mar has a 12-month low of $26.85 and a 12-month high of $105.60. The company has a 50-day simple moving average of $93.08 and a 200-day simple moving average of $76.40.

About Pharma Mar

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.